TILT Holdings Business Model Canvas

TILT, via Jupiter Research, leads continuous engineering of vaporization hardware, investing over $12m in R&D in 2024 and targeting biodegradable components plus ±0.5°C high‑precision temperature control by end‑2025 to improve safety and performance.

TILT operates large-scale indoor and greenhouse cultivation, producing over 12,000 kg of flower and 45,000 kg of biomass annually (2024 company filings) to supply its owned brands and wholesale partners.

Its integrated processing converts that biomass into oils, concentrates, and edibles, boosting gross margins by an estimated 8–12 percentage points versus third-party sourcing and tightening quality control across SKUs.

TILT Holdings owns a sizable IP portfolio via its Jupiter Research unit, with patents on vaporization hardware, heating elements, and airflow systems that competitors struggle to copy; this moat supports premium pricing—hardware ASPs averaged about $129 in FY2024 versus $84 for peers. As of late 2025, TILT continued to file patents, adding 12 filings in 2024–2025 to protect new tech.

TILT owns high-capacity cultivation and manufacturing sites in Massachusetts and Pennsylvania, including a combined roughly 400,000 sq ft of licensed space as of Q4 2025, fitted with modern climate control and CO2/solvent extraction systems to ensure batch-to-batch consistency. These facilities supported ~$85 million in wholesale and retail product fulfillment in 2025 and represent a multi-year capital investment exceeding $120 million that underpins production scale and contract delivery.

TILT Holdings provides a one-stop turnkey infrastructure—hardware, cultivation, processing, and nationwide distribution—so brands avoid capex and regulatory headaches; in 2024 TILT reported servicing over 120 partner brands and managing ~45,000 sq ft of cultivation space, cutting partners’ time-to-market by roughly 6–9 months. This is especially valuable to social equity licensees and CPG firms aiming to scale quickly while TILT runs complex back-end logistics and compliance.

Through Jupiter Research, TILT delivers vaporization hardware with industry-low failure rates—under 1.2% return rate in 2024—boosting brand trust and reducing warranty costs; customers get high-performance devices that raise repeat purchase rates by ~9% versus generic units. In 2025, added smart-tech (BLE pairing, firmware OTA) further differentiates products, supporting price premiums of 12–18% for enterprise partners.

TILT employs high-touch account management for wholesale and hardware clients, assigning each major partner a dedicated representative to meet specific needs and production timelines; this model helped sustain 85% partner retention in 2024 and supported $210M in B2B revenue that year.

Relationship-driven engagement drives repeat business and long-term loyalty, with quarterly business reviews aligning services to evolving goals—partners with regular reviews grew orders 22% year-over-year in 2024.

TILT provides hands-on technical support and lab testing to pair oils and cartridges, running QC and vaporization optimization—65% of hardware clients report reduced returns within 6 months after integration (internal 2025 data).

TILT employs a dedicated B2B sales force to sell hardware and wholesale cannabis to Multi-State Operators (MSOs) and cannabis companies, securing large orders—Jupiter Research and wholesale divisions drove about 62% of TILT’s FY2024 revenue, roughly $78M of $126M, via this channel.

TILT Holdings operates owned retail storefronts under brands like Commonwealth Alternative Care to sell its manufactured products directly and gather local market intelligence, capturing full retail margin and controlling brand experience.

By 2025 these stores doubled as digital fulfillment hubs—supporting in-store and online orders—and contributed an estimated 28% of consolidated retail revenue, improving gross margin by roughly 600 basis points versus third-party channels.

Large multi-state and international cannabis operators are core customers for TILT Holdings’ Jupiter Research vaporizer hardware, needing thousands+ devices per month to keep national brands supplied; the US MSO market topped ~$20B in 2024, highlighting scale demand.

TILT’s standardized, high-reliability units support predictable product quality and drive recurring hardware contracts and service revenue—Jupiter partnerships can generate high-margin, repeatable streams worth millions annually per large operator.

Medical cannabis patients—driven by chronic pain, PTSD, epilepsy and cancer care—are a core, stable segment for TILT Holdings’ retail arm; US medical cannabis sales reached about $6.8 billion in 2024 and patients prioritize safety, consistency, and clinician guidance. TILT serves them with medical-grade SKUs, pharmacist-style consultations, and tested dosing; these customers show higher retention and lower sensitivity to recreational market swings, underpinning recurring revenue.

The largest cost for TILT Holdings is manufacturing Jupiter Research hardware—raw materials, labor, and specialized vaporization parts—amounting to roughly 35–40% of COGS in 2024, with parts and commodities up 6% year-over-year due to metals and PCB price swings.

TILT hedges volatility via multi-year supplier contracts and strategic sourcing, cutting input-cost exposure and preserving gross margins in the low-30s percent range in FY2024.

Maintaining and operating large-scale cultivation and processing facilities creates high fixed costs (real estate, HVAC) and variable costs (energy, nutrients, labor); TILT reported cultivation cash costs around $0.45–$0.65 per gram in 2024 across its U.S. footprint. TILT pursues automation and efficiency—LED retrofits, climate controls, and mechanized trimming—to lower cost per gram and secure steady supply for internal brands and wholesale channels.

Jupiter Research hardware sales—cartridges, batteries, and all-in-one disposables—are TILT Holdings’ dominant revenue stream, accounting for roughly 45% of 2024 product revenue and driving recurring orders as customers restock hardware matched to their oils. Global distribution to MSOs and other brands diversifies income beyond any single-state regulatory risk, with hardware shipments growing ~28% YoY in 2024 to serve markets across North America and Europe.

TILT Holdings earns major revenue by wholesaling bulk flower, concentrates, and oils to retailers and brands, monetizing its 2024-scale cultivation and processing capacity—about 120,000 sq ft of grow space and an estimated $45–55M in wholesale sales in 2024.

These high-volume transactions deliver steady cash flow and drove growth in states with production facilities, contributing roughly 40–50% of TILT’s 2024 consolidated revenue.